I agree that this site is using cookies. You can find further informations here.
X
Dapavo, Paolo
178  results:
Search for persons X
?
1

Anti-IL23 in inflammatory bowel disease patients with derma..:

Ribaldone, Davide Giuseppe ; Palumbo, Andrea ; Susca, Sara...
Digestive and Liver Disease.  56 (2024)  1 - p. 220-222 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for m..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Frontiers in Immunology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Comparative effectiveness of tildrakizumab 200 mg versus ti..:

Gargiulo, Luigi ; Ibba, Luciano ; Cascio Ingurgio, Ruggero...
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
4

Treatment of Psoriasis Patients with Latent Tuberculosis Us..:

Torres, Tiago ; Chiricozzi, Andrea ; Puig, Luis...
American Journal of Clinical Dermatology.  25 (2024)  2 - p. 333-342 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Drug survival, effectiveness, and safety of brodalumab for ..:

Mastorino, Luca ; Dapavo, Paolo ; Burzi, Lorenza...
International Journal of Dermatology.  63 (2024)  7 - p. 922-928 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Clinical characteristics and response to biological therapi..:

Mastorino, Luca ; Dapavo, Paolo ; Macagno, Nicole...
International Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
7

Multi‐failure psoriasis patients: characterization of the p..:

Viola, Riccardo ; Mastorino, Luca ; Megna, Matteo...
International Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
8

Tildrakizumab: the value of a personalized and flexible app..:

Dapavo, Paolo ; Burlando, Martina ; Guarneri, Claudio...
Expert Opinion on Biological Therapy.  24 (2024)  3 - p. 133-138 , 2024
Link: https://doi.org/10.1080/..
 
?
9

Long-Term Effectiveness and Safety of Ixekizumab for the Tr..:

Valenti, Mario ; Gargiulo, Luigi ; Ibba, Luciano...
Dermatology and Therapy.  14 (2024)  6 - p. 1649-1657 , 2024
Link: https://doi.org/10.1007/..
 
?
10

New onset sarcoidosis following biologic treatment in patie..:

Donzella, Denise ; Bellis, Elisa ; Campisi, Paola...
Autoimmunity Reviews.  23 (2024)  3 - p. 103481 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Drug Survival, Safety, and Effectiveness of Secukinumab for..:

Mastorino, Luca ; Dapavo, Paolo ; Cariti, Caterina...
Journal of Personalized Medicine.  14 (2024)  7 - p. 718 , 2024
Link: https://doi.org/10.3390/..
 
?
12

Drug survival und klinische Wirksamkeit von Secukinumab, Ix..:

Mastorino, Luca ; Dapavo, Paolo ; Susca, Sara...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  22 (2024)  1 - p. 34-44 , 2024
Link: https://doi.org/10.1111/..
 
?
13

Effectiveness, Tolerability, and Drug Survival of Risankizu..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Journal of Clinical Medicine.  13 (2024)  2 - p. 495 , 2024
Link: https://doi.org/10.3390/..
 
?
14

Management of Patients Affected by Moderate-to-Severe Atopi..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Dermatology and Therapy.  14 (2024)  4 - p. 919-932 , 2024
Link: https://doi.org/10.1007/..
 
?
15

Real‐life effectiveness and safety of guselkumab in patient..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  5 - p. 1017-1027 , 2023
Link: https://doi.org/10.1111/..
 
1-15